Citations

Clear

3942 citation(s) found for "To, Van".

Sex, education and race/ethnicity have distinct effects on amyloid and tau‐PET status
Groot, Colin , Rowe, Christopher C., Giessen, Elsmarieke van de, Flier, Wiesje M. van der, Pijnenburg, Yolande A.L., Visser, Pieter Jelle, Braber, Anouk den, Pontecorvo, Michael J. , Burnham, Samantha C., Lu, Ming , Jagust, William J., Baker, Suzanne L. , Harrison, Theresa, Gispert, Juan Domingo, Shekari, Mahnaz , Minguillón, Carolina, Smith, Ruben, Mattsson‐Carlgren, Niklas, Palmqvist, Sebastian, Strandberg, Olof, Stomrud, Erik, Brickman, Adam, Manly, Jennifer J., Lao, Patrick J., Kreisl, William Charles, Malpetti, Maura, O'Brien, John T, Jäger, Elena, Bischof, Gérard, Drzezga, Alexander, Xie, Fang, Mao, Xiaoxie, Guan, Yihui, Frisoni, Giovanni B, Peretti, Débora Elisa , Skoog, I., Kern, Silke, Sperling, Reisa A., Johnson, Keith A., Risacher, Shannon, Saykin, Andrew J., Carrillo, Maria C., Dickerson, Brad C., Apostolova, Liana G., Rabinovici, Gil D., Barthel, H, Messerschmidt, Konstantin, Vandenberghe, Rik, Laere, Koen J. Van, Spruyt, Laure , Petersen, Ronald, Jack, Clifford R., Franzmeier, Nicolai, Brendel, Matthias, Gnörich, Johannes, Benzinger, Tammie L.S., Lagarde, Julien, Sarazin, Marie , Villeneuve, Sylvia , Poirier, Judes, Seo, Sang Won, Gu, Yuna , Kim, Jun Pyo, Mormino, Beth C., Vossler, Hillary , Rosa‐Neto, Pedro, Therriault, Joseph, Rahmouni, Nesrine, Cash, David M, Schott, Jonathan M, Hanseeuw, Bernard J, Jansen, Willemijn J. , Joie, Renaud La, Rosen, Howard J., Johnson, Sterling C., Christian, Bradley T, Betthauser, Tobey J., Landau, Susan M., O'Bryant, Sid E., Hansson, Oskar H., Ossenkoppele, Rik, Prevent‐AD, ADNI, ADNI‐DOD, A‐Study, MCSA,, O’Brien, John T. , O'Brien, John Tiernan , Groot, Colin , Coomans, Emma M. , Rowe, Christopher C., Doré, Vincent , Feizpour, Azadeh , Giessen, Elsmarieke van de , Flier, Wiesje M. van der , Pijnenburg, Yolande A.L. , Visser, Pieter Jelle , Braber, Anouk den , Burnham, Samantha C. , Kennedy, Ian Andrew , Jagust, William J. , Harrison, Theresa M. , Gispert, Juan Domingo , Shekari, Mahnaz , Minguillón, Carolina , Smith, Ruben, Mattsson, Niklas , Palmqvist, Sebastian , Strandberg, Olof, Stomrud, Erik , Brickman, Adam M. , Luchsinger, Jose Alejandro , Manly, Jennifer J. , Lao, Patrick , Malpetti, Maura , Rowe, James B. , Bischof, Gérard N. , Drzezga, Alexander E. , Xie, Fang , Guan, Yihui , Garibotto, Valentina , Frisoni, Giovanni B. , Schöll, Michael , Kern, Silke , Sperling, Reisa Anne , Johnson, Keith A. , Risacher, Shannon L. , Saykin, Andrew J. , Carrillo, María C. , Dickerson, Bradford Clark , Apostolova, Liana G. , Rabinovici, Gil D. , Rullmann, Michael , Messerschmidt, Konstantin, Vandenberghe, Rik , Petersen, Ronald, Jack, Clifford R. , Franzmeier, Nicolai , Brendel, Matthias , Gnörich, Johannes , Benzinger, Tammie L.S. , Lagarde, Julien , Bottlaender, Michel , Poirier, Judes , Seo, Sang Won , Kim, Jun Pyo, Young, Christina B. , Rosa-Neto, Pedro , Therriault, Joseph , Rahmouni, Nesrine , Coath, William , Cash, David M. , Schott, Jonathan M. , Hanseeuw, Bernard , Salman, Yasmine , Malotaux, Vincent , Joie, Renaud La , Rosen, Howard J. , Johnson, Sterling C. , Christian, Bradley T. , Betthauser, Tobey J. , Landau, Susan , O’Bryant, Sid E. , Hansson, Oskar , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 8, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_105387 Get It

Abstract Background Sex, education and race/ethnicity are all associated with risk of Alzheimer's disease dementia. Here, we assess the effects of self‐reported sex, educational attainment and race/ethnicity on amyloid‐positivity, and tau‐PET‐positivity in 12,048 (7,394 cognitively unimpaired [CU], 2,177 MCI, and 2,477 dementia) individuals from 42 cohorts worldwide. Method Logistic generalized estimating equations were used to estimate frequency of amyloid‐positivity (using cohort‐specific thresholds for amyloid‐PET [84%] or CSF) and tau‐PET‐positivity (cohort‐specific thresholds of 2SD above mean temporal uptake in amyloid‐negative controls). We assessed: i) sex and APOEε4 ( N = 10,098) associations, to complement earlier findings of a higher frequency of tau‐positivity in females, ii) effects of lower/higher education ( N = 10,970; cohort‐specific median‐split), and iii) effects of race/ethnicity (non‐Hispanic White [hereafter: White], N = 4880; Asian, N = 116; Black or African‐American [hereafter: Black], N = 353; Hispanic, N = 356, only from Northern‐American cohorts). Outcomes were frequency of amyloid‐positivity in CU individuals only, and tau‐PET‐positivity in both amyloid‐positive (AB+) CU and cognitively impaired (CI, i.e. MCI and dementia) individuals. Interaction effects on the relationship between age and amyloid/tau‐positivity were assessed and only retained in the models when significant. Result Female sex was associated with an APOEε4 ‐independent increased frequency of amyloid‐positivity (β=0.51[0.22], p = 0.02) in CU and increase of tau‐positivity in both AB+CU (β=0.27[0.08]) and AB+CI (β=0.37[0.08], both p <0.01). Remarkably, tau‐positivity frequencies of female APOEε4 non‐carriers were equivalent to male APOEε4 carriers in AB+CI (Figure 1). No significant sex* APOE interactions were observed. In CU, higher education was associated with lower amyloid‐positivity frequency (β=‐0.12[0.05], p = 0.02). In contrast, among AB+CU, there was an age*education interaction effect that indicated more pronounced age effects on tau‐positivity in individuals with higher education (age*education:β interaction =0.03[0.01], p <0.01). There were no education effects in AB+CI (Figure 2). In CU, an age*race/ethnicity interaction effect was observed across all non‐White groups compared to White (Hispanic:β interaction =‐0.05[0.01], p <0.01; Black:‐0.04[0.01], p <0.01; Asian:‐0.02[0.01], p = 0.04). This suggests that the impact of age on amyloid‐positivity was less pronounced in non‐White groups. Furthermore, in AB+CI, Hispanic ethnicity was related to higher tau‐positivity frequency than White (β=0.51[0.22], p = 0.02; Figure 3). Conclusion In this multi‐center initiative comprised of clinical and community‐based cohorts, we observed that self‐reported sex, educational attainment and race/ethnicity were related to positivity‐frequencies of Alzheimer's disease pathology.
Structured Nurse-Led PICU Liberation Bundle (ABCDEF) Discussion During Rounds: A Single-Center, Secondary Analysis of Pre- Vs. Post-Implementation Data From 2017
Fashina, Oluwatomini A. , Kahoud, Robert J., Rohlik, Gina, Mujic, Anna J., Vu, Joshua K., Matzke, Nanette, Aganga, Devon O. , Gleich, Stephen J. , Schears, Gregory J. , Dorn, Charlotte S. Van, Crow, Sheri, Schiltz, Brenda , Ouellette, Yves , Arteaga, Grace M., Kawai, Yu , Rohlik, Gina M, Vu, Joshua, Nemergut, Michael E. , Matzke, Nanette E, Van Dorn, Charlotte S, Schiltz, Brenda M, Kawai, Yu , Fashina, Oluwatomini, Mujic, Anna J., Dorn, Charlotte S. Van , Arteaga, Grace M.

Mayo Clinic

Pediatric Critical Care Medicine | January 8, 2026 | Volume: 27 | Issue: 1 | Pages: 72-81

10.1097/pcc.0000000000003869 | PMID 41504574 Get It

Objective: The Society of Critical Care Medicine PICU Liberation ABCDEF (A–F) Campaign Collaborative aimed to implement best practices for analgesia (A), breathing (B), comfort/consciousness (C), delirium (D), early mobilization (E), and family engagement and empowerment (F). Our post hoc study of Mayo Clinic data sought to compare the pre-implementation rounding process, which used a nursing script organized by organ systems, with a novel, liberation-focused rounding process emphasizing A–F bundle elements. Design: Secondary analysis of pre- vs. post-implementation surveys collected by independent observers during rounds. Setting: Medical/surgical PICU in a quaternary-care, academic medical center during April to July 2017. Subjects: The observed participants included PICU physicians, nurses, respiratory therapists, pharmacists, and dietitians. Interventions: None. Measurements and Main Results: Survey responses from 145 team members pre-implementation and 67 post-implementation showed improved team satisfaction, communication, and understanding of daily plans (all p < 0.05). Respondents reported an increased frequency of discussions on bundle components A–E (all p < 0.01). Observations of 41 pre-implementation and 46 post-implementation rounds showed an increase in the frequency of discussion of all components of the bundle (all p < 0.01). However, this finding was not at the expense of increased duration of individual rounds since we failed to find a difference in pre- vs. post-implementation duration per patient (480 vs. 544 s per patient, p = 0.20). Conclusions: In 2017, around the time of introducing the nurse-led PICU Liberation rounding process to our practice, we found that after implementation, there was an associated increase in discussions about bundle elements and improved communications and satisfaction in team members.
Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
Parlow, Simon, Jung, Richard G. , Almoosawy, Sayed Abdulmotaleb , Lepage-Ratte, Melissa Fay , Durr, Michael, Mathieu, Marie-Eve , Santo, Pietro Di, Motazedian, Pouya, Sterling, Lee H., Abdel-Razek, Omar, Fan, Eddy, Thiele, H., Price, Susanna, Diepen, Sean van, Visintini, Sarah , Basir, Mir B., Kapur, Navin K. , Hibbert, Benjamin, Tran, Alexandre, Møller, J. T., Rochwerg, B., Mathew, R., Parlow, Simon , Fernando, Shannon M , Parlow, Simon , Durr, Michael-Roy R, Mathieu, Marie-Eve, Santo, Pietro Di , Motazedian, Pouya , Abdel‐Razek, Omar , Fan, Eddy , Price, Susanna , Diepen, Sean van , Basir, Mir B. , Hibbert, Benjamin , Tran, Alexandre , Rochwerg, Bram , Mathew, Rebecca , Fernando, Shannon M.

Mayo Clinic

Critical Care Medicine | January 8, 2026 | Volume: 54 | Issue: 3 | Pages: 584-593

10.1097/ccm.0000000000007013 | PMID 41504526 Get It

Objectives: To identify factors associated with short-term mortality among patients receiving microaxial flow pump (mAFP) therapy for acute myocardial infarction-related cardiogenic shock (AMI-CS). Data Sources: We searched four databases (MEDLINE, Embase, CENTRAL, and Scopus) from January 1, 2004, to January 1, 2025. Study Selection: We selected English-language studies that included adults with AMI-CS receiving mAFP and evaluated factors associated with short-term mortality. We excluded patients receiving concurrent venoarterial extracorporeal membrane oxygenation, as well as studies that solely included patients presenting with out-of-hospital cardiac arrest. Data Extraction: Two authors performed citation screening and data extraction. For each factor evaluated in at least two studies, we performed meta-analyses of adjusted odds ratios (aORs) using a random-effects model. Risk of bias was evaluated using the Quality in Prognosis Studies tool, and the certainty of evidence was evaluated using Grading of Recommendations, Assessment, Development, and Evaluations methodology. Data Synthesis: Our primary analysis included 18 studies, encompassing 20,617 patients. Median short-term mortality across studies was 50.7% (interquartile range 38.4–55.3%). Factors associated with short-term mortality based on high-certainty evidence included: increased age (aOR, 1.04 per year [95% CI, 1.03–1.05 per year] or ≥ 65 yr (aOR, 2.42 yr [95% CI, 0.77–7.64 yr]), female sex (aOR, 1.26 [95% CI, 1.09–1.45]), higher body mass index (aOR, 1.05 per point [95% CI, 1.04–1.07 per point]), higher heart rate (aOR, 1.02 per beats/min [95% CI, 1.01–1.02 per beats/min]), higher serum creatinine (aOR, 1.35 per mg/dL [95% CI, 1.08–1.70 per mg/dL]), mechanical ventilation (aOR, 2.53 [95% CI, 1.82–3.53]), vasopressors (aOR, 1.52 [95% CI, 1.11–2.08] for any vasopressors and aOR, 1.37 [95% CI, 1.18–1.58] per each vasopressor), presentation with ST-elevation myocardial infarction (aOR, 1.59 [95% CI, 1.11–2.26]), cardiac arrest (aOR, 2.85 [95% CI, 2.22–3.64]), and hypoxic-ischemic brain injury (aOR, 5.36 [95% CI, 3.03–9.47]). Conclusions: We identified several prognostic factors associated with short-term mortality in AMI-CS patients receiving mAFP support. This work may help inform clinicians, patients, and families regarding utilization of mAFP in AMI-CS.
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)
Kim, Aerang, Ballman, K., Wolters, Pamela L. , Heise, Rachel S. , Shern, J., Sundby, R. Taylor , Lindenberg, Liza , Lee, Min-Jung , Rastogi, Shraddha , Shahsavari, Shirin, Tine, Brian A. Van, Meyer, Christian F. , Pratilas, Christine A. , Collins, Natalie B. , Coyne, Geraldine O'Sullivan, Chen, Alice P. , Dombi, Eva, Shrestha, Roshan L., Cichowski, Karen M. , Widemann, B. C., Ballman, Karla V. , Kim, AeRang , Cichowski, Karen , Shern, Jack F. , Sundby, R. Taylor , Kim, AeRang , Ballman, Karla , Shern, Jack F , Sato, Nahoko , Shahsavari, Shirin , Hirbe, Angela C , Van Tine, Brian A , Meyer, Christian , Pratilas, Christine A , Collins, Natalie B , O'Sullivan Coyne, Geraldine , Chen, Alice P , Dombi, Eva , Shrestha, Roshan L , Gross, Andrea M , Reinke, Denise , Widemann, Brigitte C , Heise, Rachel , Wolters, Pamela L. , Hirbe, Angela C. , Tine, Brian A. Van , Dombi, Eva , Gross, Andrea M. , Reinke, Denise K.

Mayo Clinic

Clinical Cancer Research | January 8, 2026 | Volume: 32 | Issue: 6 | Pages: 1068-1077

10.1158/1078-0432.ccr-25-2887 | PMID 41504652 Get It

Abstract Purpose: Combined mTOR and MEK inhibition, critical components of the RAS effector pathway underlying the pathogenesis of neurofibromatosis type 1 (NF1)–related tumors, caused regression in a malignant peripheral nerve sheath tumor (MPNST) transgenic mouse model. The primary objective was to determine the clinical benefit rate in patients with unresectable/metastatic MPNST. Patients and Methods: The study design was a multi-institutional, open-label, Simon two-stage, phase II study of the MEK inhibitor selumetinib and mTOR inhibitor sirolimus. Patients ≥12 years with histologically confirmed MPNST received selumetinib 50 mg twice daily and sirolimus 4 mg once daily, in continuous 28-day cycles. Correlative studies evaluated patient-reported pain, immune signature in peripheral blood, and cell-free DNA (cfDNA). Results: A total of 21 heavily pretreated patients [seven females; median age, 41 years (range, 16–72); and 14 with NF1] with advanced disease enrolled at five participating sites. Clinical benefit was observed in only one of seven in stage 1 and one of 14 patients in stage 2. The median number of cycles was two (range, 1–6). Most common adverse events (AE) were grade ≤2 gastrointestinal toxicity, acneiform rash, hypertriglyceridemia, mucositis, and transaminase elevation. Unlike the preclinical model, early 18F-fluorodeoxyglucose PET scan performed during cycle 1 demonstrated partial metabolic responses in five patients (24%), but these did not correlate with objective responses after cycle 2. cfDNA was able to detect MPNST with the potential to be a biomarker of response. Conclusions: The combination was safe, with manageable and expected AEs, but did not meet study parameters for further evaluation in MPNST. Correlative studies were informative and may guide future therapeutic trials of MPNST.
Heterogeneous tau patterns in atypical AD are explained by connectivity‐associated tau progression
Bruin, Hannah de , Groot, Colin , (ADNI), Alzheimer's Disease Neuroimaging Initiative, Barthel, Henryk, Bischof, Gérard N. , Boon, Baayla D.C., Brendel, Matthias, Cash, David M, Day, Gregory S, Dickerson, Brad C., Dyck, Christopher H van, Flier, Wiesje M. van der, Fredericks, Carolyn , Fryer, Tim D. , Giessen, Elsmarieke van de, Gordon, Brian A., Radford, Jonathan Graff, Hansson, Oskar H., Höglinger, Günter U, Hönig, Merle C., Irwin, David J., Jones, P Simon, Josephs, Keith A., Katsumi, Yuta , Lee, Eddie B., Xiong, Chengjie , McGinnis, Scott M., Mecca, Adam P. , O'Brien, John T, O'Dell, Ryan S, Rabinovici, Gil D., Rahmouni, Nesrine, Rosa‐Neto, Pedro, Sabri, Osama, Schott, Jonathan M, Schroeter, Matthias L, Seeley, William W., Servaes, Stijn, Sintini, Irene , Smith, Ruben, Stevenson, Jenna , Strandberg, Olof, Therriault, Joseph, Tideman, Pontus , Touroutoglou, Alexandra , Trainer, Anne, Wekselman, Fattin, Weston, Philip SJ., Whitwell, Jennifer L., Yong, Keir X X, O’Brien, John T. , Rabinovici, Gil D. , Day, Gregory S. , O'Brien, John Tiernan , Day, Gregory S , Xiong, Chengjie , Rabinovici, Gil D , Groot, Colin , Initiative, Alzheimer's Disease Neuroimaging, Blazhenets, Ganna , Boellaard, Ronald , Boon, Baayla D.C. , Brendel, Matthias , Cash, David M. , Coath, William , Dickerson, Brad C., Doering, Elena , Drzezga, Alexander E. , Dyck, Christopher H. van , Eimeren, Thilo van , Flier, Wiesje M. van der , Giessen, Elsmarieke van de , Gordon, Brian A. , Grinberg, Lea T. , Hansson, Oskar , Hobbs, Diana A. , Höglinger, Günter U. , Irwin, David J. , Jones, Peter Simon , Josephs, Keith A. , Joie, Renaud La , Lee, Eddie B, Malpetti, Maura , Mohanty, Rosaleena , Nasrallah, Ilya M. , O’Dell, Ryan S. , Palleis, Carla , Perneczky, Robert , Phillips, Jeffrey S , Putcha, Deepti , Rahmouni, Nesrine , Rosa-Neto, Pedro , Rowe, James B. , Rullmann, Michael , Saur, Dorothee , Schildan, Andreas , Schott, Jonathan M. , Schroeter, Matthias L , Seeley, William W. , Servaes, Stijn , Spina, Salvatore , Stomrud, Erik , Therriault, Joseph , Visser, Denise , Weston, Philip S.J. , Whitwell, Jennifer L. , Wolk, David A. , Yong, Keir , Pijnenburg, Yolande A.L. , Franzmeier, Nicolai , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 7, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_104871 Get It

Abstract Background The link between regional tau load and clinical manifestation of Alzheimer's disease (AD) highlights the importance of characterizing spatial tau distribution. In typical (memory‐predominant) AD, the spatial progression of tau pathology mirrors the functional connections from temporal lobe epicenters. However, atypical (non‐amnestic‐predominant) AD variants with heterogeneous tau patterns provide a key opportunity to assess the universality of connectivity as a scaffold for tau progression. Method We included tau‐PET data from 320 subjects with atypical AD, characterized by highly heterogeneous tau patterns ( n = 139 posterior cortical atrophy/PCA‐AD; n = 103 logopenic variant primary progressive aphasia/lvPPA‐AD; n = 35 behavioural variant AD/bvAD; n = 43 corticobasal syndrome/CBS‐AD) from 14 sites, with a subset of patients ( n = 78) having longitudinal tau‐PET data. As an independent sample, we further included regional post‐mortem tau stainings from 93 atypical AD patients from two sites ( n = 19 PCA‐AD, n = 32 lvPPA‐AD, n = 23 bvAD, n = 19 CBS‐AD). Gaussian mixture modeling was used to harmonize different tau‐PET tracers by transforming tau‐PET standardized uptake value ratios to tau positivity probabilities (a uniform scale ranging from 0% to 100%). Using linear regression, we assessed whether 1) brain regions with stronger functional connectivity showed greater covariance in cross‐sectional and longitudinal tau‐PET and post‐mortem tau pathology, and 2) functional connectivity of tau‐PET epicenters and tau‐PET accumulation epicenters was associated with cross‐sectional and longitudinal tau patterns. Result Tau‐PET epicenters—defined as the 5% brain regions with the highest tau load—aligned with clinical variants, e.g. a posterior pattern in PCA‐AD (“visual AD”) and left‐hemispheric temporal predominance in lvPPA‐AD (“language AD”) (Figure 1). More strongly functionally connected regions showed correlated concurrent tau‐PET levels, which was confirmed with post‐mortem data (Figure 2). Moreover, the connectivity profile of tau‐PET epicenters and accumulation epicenters corresponded to tau‐PET progression patterns (Figure 3). Conclusion Our data are consistent with the hypothesis that tau propagation occurs along functional connections originating from local epicenters, across all AD clinical variants. Since tau proteinopathy is a key driver of neurodegeneration and cognitive decline, this finding may advance personalized medicine and participant‐specific endpoints in clinical trials.
Functional and Transcriptional Senescence Profiles of CD8+ T Cells Associate With the Presence of Carotid Plaques in People Living With HIV
Blaauw, Marc J T , Navas, Adriana , Vásquez, Victoria Rios, Berrevoets, M. C., Otten, Twan , Vos, W. A. G. H. , Eekeren, Louise van, Groenendijk, Albert, Lutgens, Esther, Koenen, Hans J P M, Netea, M, Rutten, J R, Otten, Twan , Rutten, Joost H W , van der Ven, Andre J A M , Rios-Vazquez, Victoria , Vadaq, Nadira , Berrevoets, Marvin A. H. , Eekeren, Louise E. van , Groenendijk, Albert L. , Weijers, Gert , Lutgens, Esther , Koenen, Hans J. P. M. , Jonge, Marien Isaäk de , Riksen, Niels P.

Mayo Clinic

The Journal of Infectious Diseases | January 6, 2026 | Volume: 233 | Issue: 5 | Pages: e1154-e1164

10.1093/infdis/jiag018 | PMID 41498526 Get It

Abstract Background People living with HIV (PLHIV) are at increased risk of atherosclerotic cardiovascular disease (ASCVD), but the immunological mechanisms driving plaque formation remain unclear. This study investigated the association between peripheral immune cell subsets and carotid atherosclerotic plaques in PLHIV without prior clinical ASCVD. Methods In this multi-center cross-sectional study, virally suppressed PLHIV receiving antiretroviral therapy were enrolled from two Dutch cohorts: a discovery cohort (n = 994) and a validation cohort (n = 200). Participants underwent carotid ultrasound imaging to assess plaques using standardized criteria. Immune profiling was performed using high-dimensional flow cytometry of 355 immune cell populations. Associations with plaque were analyzed using linear regression adjusted for relevant confounders, and key findings were validated in the second cohort. Transcriptomic profiles of main cell populations were evaluated using deconvoluted bulk RNA sequencing to identify differential expression and pathway enrichment. Results Carotid plaques were present in 584 participants (49%)—502 of 994 (51%) in the discovery and 82 of 200 (41%) in the validation cohort. Plaques were associated with higher counts of several CD8+ T cell subsets, particularly PD-1-expressing cytotoxic T cells with an interferon secretion profile (CD8TC1PD1+). Transcriptomic analysis of CD8+ T cells revealed downregulated mitochondrial function and upregulated type 1 interferon and epidermal growth factor receptor signaling, indicating a senescent phenotype. Conclusions CD8+ T cell senescence may contribute to early atherosclerotic plaque formation in PLHIV. Targeting immune senescence could offer a novel strategy for cardiovascular risk reduction in this population. Clinical Trials Registration ClinicalTrials.gov Identifier: NCT03994835
The E-AHPBA—ESSO—Innsbruck consensus recommendations on peri- and postoperative management following liver resection
Maier, Eva , Stättner, Stefan, Carrión-Álvarez, Lucía , Martino, Marcello Di, Primavesi, Florian, Sochorová, Dana , Laarhoven, Stijn van , Balakrishnan, Anita, Buis, Carlijn I. , Cipriani, Federica, Erdmann, Joris, Frampton, A., Fuks, David, Melloul, Emmanuel, Oberkofler, Christian E. , Petritsch, Stefan, Raab, Helmut, Rahbari, Nuh N. , Rappold, Daniela , Ruzzenente, Andrea, Schäfer, Benedikt , Serrablo, Alejandro, Soreide, Kjetil, Ernesto, Sparrelid, Starlinger, Patrick P, Tinguely, Pascale, Dasari, Bobby V M, Donadon, Matteo, Dopazo, Cristina, Gruenberger, T., Jonas, E G, Malik, Hassan, Siriwardena, Ajith K, Braunwarth, Eva , Di Martino, Marcello , Olthof, Pim , van Laarhoven, Stijn , Cipriani, Federica , Erdmann, Joris I , Lancellotti, Francesco , Oberkofler, Christian , Sallinen, Ville , Søreide, Kjetil , Starlinger, Patrick , Aldrighetti, Luca , Donadon, Matteo , Dopazo, Cristina , Gruenberger, Thomas , Viganó, Luca , Maglione, Manuel , Stättner, Stefan , Primavesi, Florian , Breitkopf, Robert , Fuks, David , Gilg, Stefan , Gulla, Aistė , Margreiter, Christian , Reiberger, Thomas , Ruzzenente, Andrea , Schaefer, Benedikt, Schnitzbauer, Andreas A. , Søreide, Kjetil , Sparrelid, Ernesto , Starlinger, Patrick , Stavrou, Gregor Alexander , Aldrighetti, Luca , Dasari, B. , Gruenberger, Thomas , Jonas, Eduard , Malik, Hassan , Siriwardena, Ajith K. , Maglione, Manuel

Mayo Clinic

British Journal of Surgery | December 30, 2025 | Volume: 113 | Issue: 1 | Pages: No page available

10.1093/bjs/znaf272 | PMID 41467576 Get It

Abstract Background Liver surgery carries a high risk of complications due to the complex interplay of patient-related factors, disease characteristics, and liver function. Expertise is essential for healthcare professionals managing hepatobiliary patients. This European consensus provides evidence-based guidance on selected aspects of peri- and postoperative care. Methods A modified Delphi process was used to achieve consensus, with a 70% agreement threshold. The expert panel comprised hepatobiliary surgeons, anaesthetists, hepatologists, a specialist nurse, and a physiotherapist. A systematic literature search was conducted in PubMed/MEDLINE, Embase, Web of Science, and Cochrane databases. Six topics were addressed: thromboprophylaxis; perioperative antibiotics; prehabilitation/nutrition/mobilization; bile leak including bilioenteric anastomosis leaks; post-hepatectomy haemorrhage; and post-hepatectomy liver failure (PHLF). Evidence appraisal and statement development followed Scottish Intercollegiate Guidelines Network methodology. A patient representative reviewed the guideline. Results Searching the literature yielded 204 included publications from an initial 6514. Thirty-two statements were formulated with a median evidence level of 2. Evidence strength varied by topic with noticeably lower evidence levels in complex surgery settings and less prevalent conditions. In some topics, study heterogeneity and specific inclusion criteria resulted in conditional recommendations, despite high-level evidence. Notably, the weakest evidence was found for perioperative thromboprophylaxis and PHLF management. Strong recommendations were formulated for prehabilitation, early postoperative mobilization, and avoidance of routine drain use. Several evidence gaps warranting multicentre studies were identified. Conclusion Optimizing peri- and postoperative care after liver resection remains challenging. Standardizing key practices and addressing evidence gaps through collaborative research are vital to improve outcomes.
Home Time Following Emergency Department Visits Among People With Dementia
Zepel, Lindsay , Smith, V. Kerry , Bellolio, Fernanda, Houtven, Courtney H. Van , Hastings, Susan N., Seidenfeld, Justine , Smith, Valerie A., Vashi, Anita A. , Hastings, S. Nicole

Mayo Clinic

JAMA Network Open | December 29, 2025 | Volume: 8 | Issue: 12 | Pages: e2549154

10.1001/jamanetworkopen.2025.49154 | PMID 41632170 Get It

Importance Emergency department (ED) visits for people with dementia often involve care (including the admission or discharge decision) with lasting effects on quality of life. Home time—a claims-based measure of days alive and outside of institutional care—provides a patient-centered way to assess downstream outcomes of ED care in this population. Objective To examine variations in home time following an ED visit by patient, facility, and visit characteristics among veterans with dementia. Design, Setting, and Participants This national retrospective cohort study used US Department of Veterans Affairs (VA) health care system data sources. Participants were veterans aged 65 to 110 years with dementia with an eligible Veterans Health Administration ED visit in fiscal years 2017 (October 1, 2016, through September 30, 2017) and/or 2018 (October 1, 2017, through September 30, 2018). Data were analyzed from May 1, 2024, to May 15, 2025. Exposures Patient, ED facility, and ED visit factors. Main Outcomes and Measures Home time, operationalized for modeling as days not at home in the 180 days after the index ED visit. Associations between patient, ED facility, and ED visit characteristics and home time were assessed using a negative binomial model. Results The study included 51 707 veterans with dementia (mean [SD] age, 79.9 [8.59] years; 97.6% male; 52.2% married). The mean (SD) number of days not at home within 180 days was 21.7 (34.5). Of the total cohort, 4.5% never returned home in the 180 days after their ED visit, while 18.2% had all subsequent days at home. ED admission (vs discharge) disposition was the factor associated with the largest increase in days not at home (rate ratio [RR], 3.18; 95% CI, 3.08-3.29). Patient factors associated with more days not at home included very high frailty (RR, 1.27; 95% CI, 1.21-1.33), unhoused status (RR, 1.50; 95% CI, 1.39-1.63), unmarried status (never married: RR, 1.24 [95% CI, 1.16-1.32]; divorced, separated, or widowed: RR, 1.24 [95% CI, 1.20-1.28]), and depression (RR, 1.13; 95% CI, 1.09-1.17). Conclusions and Relevance The findings of this cohort study suggest that home time offers a patient-centered measure of post-ED outcomes for individuals with dementia. Future work should refine its application, particularly regarding the ED disposition decision, to better evaluate the long-term impact of ED care decisions.
T cells use TNF and IFNγ for paracrine killing with target discrimination programmed by pathogen-derived factors
Guttormson, Matthew C. , Krogman, Erica N., Carr, Allison R. , Rizzo, Skylar A. , Muske, Josey , Ziaee, Maia , Therrien, Nicholas R. , Sun, N , Ghale, Romina , Medlyn, Michael J. , Billadeau, Daniel D. , Pease, Larry R. , Ting, Adrian T. , Rizzo, Skylar A , Sun, Nicholas D , Knoop, Kathryn A.

Mayo Clinic

No container title available | December 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2025.12.23.696308 Get It

ABSTRACT Cytotoxic T lymphocytes (CTLs) are known to eliminate target cells through perforin-mediated, contact-dependent killing - a process limited by the number of effector T cells despite its serial nature. CTLs likely also possess a mass killing mechanism that can eliminate target cells more efficiently. Using CAR-T cells against B7H3 present on B16 tumor targets, we demonstrate that activated T cells can also kill targets in a perforin-independent manner by releasing diffusible TNF and IFNγ capable of killing nearby targets in a paracrine fashion even if they bear no antigen. Against an unperturbed target, paracrine killing is inefficient but is enhanced by the deletion of TNFR1 signaling molecules such as TAK1, HOIP, or TBK1/IKKε. Notably, these molecules are inhibited naturally by pathogen-encoded antagonists. Expression of a microbial-encoded antagonist, such as the Yersinia -encoded YopJ that antagonizes TAK1 or Ebola-encoded VP35 that antagonizes TBK1/IKKε, alters the target cell response to these cytokines from non-lethal to lethal. We propose that target cells are inherently resistant to killing by TNF and IFNγ, but the presence of a microbial factor alters this sensitivity, providing for the selective elimination of the infected cell while minimizing harm to uninfected bystander cells. We propose the term ‘pathogen-restriction’ to describe this discriminatory mechanism. Potentially, any microbial-derived factor that crosstalks with the TNF and IFNγ signaling pathways can function as a pathogen-restriction element. GRAPHICAL ABSTRACT Short Summary T cells use TNF and IFNγ to kill target cells in a paracrine manner where target elimination is restricted by the presence of pathogen-derived factors.